Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

 
 
Session Overview
Date: Wednesday, 29/May/2024
2:00pm
-
5:00pm
WS: SCNP EDUCATIONAL WORKSHOP 2024
Location: Institute of Neuroscience and Physiology
Chair: Bo Söderpalm
Chair: Andrea de Bejczy
DRUG DISCOVERY IN PSYCHIATRY – PATENT ISSUES – PERFORMING CLINICAL TRIALS IN PSYCHIATRY – INDUSTRY PERSPECTIVES

Date: Thursday, 30/May/2024
9:00am
-
9:25am
GA: SCNP GENERAL ASSEMBLY (MEMBERS ONLY)
Location: Hotel Draken, Göteborg
Chair: Sophie Erhardt
SCNP GENERAL ASSEMBLY (MEMBERS ONLY)
9:25am
-
9:30am
PL1: PRESIDENTS’ WELCOME
Location: Hotel Draken, Göteborg
Chair: Sophie Erhardt
Chair: Bo Söderpalm
SCNP PRESIDENTS’ WELCOME TO SCNP 62nd ANNUAL MEETING
9:30am
-
10:15am
PL2: SCNP 2024 OPENING LECTURE
Location: Hotel Draken, Göteborg
Chair: Sophie Erhardt
 

Is bipolar disorder neuroprogressive? Insights into brain structure, cognition, and biomarkers from longitudinal investigations

Mikael Landén

10:00am
-
4:30pm
PO: Poster Session
 

Exploring Astrocyte-Derived KYNA in Schizophrenia: Insights from a 3D Spheroid Model and Drug Screening Platform

Funda Orhan, Tian Sang, Xueqi Li, Marta Gomez, Sophie Erhardt



A New Pharmacological Treatment Concept for Alcohol Use Disorder: Combined Treatment With a Glycine Transporter-1-Inhibitor, Varenicline and Bupropion

Yasmin Olsson, Helga Lidö, Karin Ademar, Davide Cadeddu, Mia Ericson, Bo Söderpalm



Dysregulation of the kynurenine pathway is related to persistent cognitive impairments in TBE patients

Xueqi Li, Jacob Ahlberg Weidenfors, Vytautas Griška, Fredrik Piehl, Lars Lindquist, Aukse Mickiene, Lilly Schwieler, Sophie Erhardt



Innovative CSF collection technique for rats: Understanding kynurenine pathway metabolite translation across brain, plasma and CSF

Varvara Louvrou, Marta Gómez Galán, Sophie Erhardt



Neurophysiological signatures in the Basolateral Amygdala associated with an AUD-like phenotype in rat

Davide Cadeddu, Ana Domi, Erika Lucente, Louise Adermark



Integrative analysis multi-omics analysis of proteomics and metabolomics data of Karolinska Schizophrenia Project (KaSP)

Feride Ayten Eren, Humza Haroon, Sophie Erhardt, Doo-Sup Choi



Nicotine produces sex-specific neuroadaptations in the amygdala which in female rats can be reversed by physical activity

Erika Lucente, Ana Domi, Davide Cadeddu, Mia Ericson, Louise Adermark



Pharmacological treatment of the core symptoms of Anorexia nervosa – a systematic literature review

Elin Ingrid Munke, Jonas Eberhard, Erik Jedenius, Charalampos Vestakis



Polygenic Risk Score Analysis of Postpartum Psychosis and Cycloid Psychosis

Elin Hörbeck, Lina Jonsson, Carl Sellgren, Mikael Landén



THE ACETYLCHOLINE ESTERASE INHIBITOR DONEPEZIL INCREASES ACCUMBAL DOPAMINE LEVELS AND BLOCKS THE ALCOHOL DEPRIVATION EFFECT IN RATS

Anna Loftén, Klara Danielsson, Louise Adermark, Mia Ericson, Bo Söderpalm



The Pharmacological Effect of Acamprosate Originates from Different Drug Components

Karin Ademar, Anna Loftén, Mathilda Nilsson, Ana Domi, Louise Adermark, Bo Söderpalm, Mia Ericson

10:15am
-
10:45am
BR1: COFFEE BREAK AND POSTER VIEWING
Location: Hotel Draken, Göteborg
10:45am
-
12:15pm
S1: Alcohol Use Disorder
Location: Hotel Draken, Göteborg
Chair: Bo Söderpalm
 

Is bipolar disorder neuroprogressive? Neurobiological mechanisms of compulsive alcohol use

Markus Heilig



The COMB-study; a multicenter RCT on the effects of varenicline and bupropion in alcohol use disorder.

Andrea de Bejczy, Bo Söderpalm, Johan Franck, Anders Håkansson, Markus Heilig



Sodium oxybate: a substitution therapy for alcohol use disorder?

Julien Guiraud

12:15pm
-
1:30pm
BR2: LUNCH AND POSTER VIEWING
Location: Hotel Draken, Göteborg
1:30pm
-
3:00pm
S2: SCNP YOUNG SCIENTIST SYMPOSIUM
Location: Hotel Draken, Göteborg
Chair: Gregers Wegener
 

Exploring the cerebrospinal fluid proteome in bipolar disorder

Andreas Göteson, Lina Jonsson, Aurimantas Pelanis, Erik Pålsson, Henrik Zetterberg, Kaj Blennow, Jessica Holmén-Larsson, Johan Gobom, Mikael Landén



In vivo evidence that interactions between dopaminergic and serotonergic receptors underlie the complex impact of the dopamine stabiliser (-) OSU6162 on psychomotor activity

Daniela Atanasovski, Elias Eriksson



Integrative analysis multi-omics analysis of proteomics and metabolomics data of Karolinska Schizophrenia Project (KaSP)

Feride Ayten Eren, Humza Haroon, Sophie Erhardt, Doo-Sup Choi



A Macrobiotic Approach to Ameliorate "Chemo-brain" and Chemotherapy-induced Sickness

Eleonora Genovese, Bradley Whitehead, Gregers Wegener, Peter Nejsum, Cecilie Bay-Richter



Molecular Interaction of Antidepressants with Estrogen Receptor Alpha

Shokouh Arjmand, Rachele Rossi, Christian B. Vægter, Steffen Sinning, Heidi K. Müller, Birgit Schiøtt, Claudia Cecchi, Jayashree Sahana, Anne M. Landau, Gregers Wegener, Sâmia Joca, Caroline Biojone



Selective manipulation of striatal dopamine

Klara Danielsson, Rosita Stomberg, Louise Adermark, Mia Ericson, Bo Söderpalm

3:00pm
-
3:45pm
BR3: COFFEE BREAK AND POSTER VIEWING
Location: Hotel Draken, Göteborg
3:45pm
-
4:30pm
PL3: SCNP LECTURE - DEPRESSION
Location: Hotel Draken, Göteborg
Chair: Halldóra Jónsdóttir
 

New treatment options in TRD: hope or hype?

Andreas Reif

4:30pm
-
4:45pm
BR4: Walk to PADDAN tour
Location: Hotel Draken, Göteborg
6:30pm
-
10:00pm
DI: SCNP 2024 Dinner
Location: Hotel Draken, Göteborg

Date: Friday, 31/May/2024
8:30am
-
10:00am
S3: ADHD
Location: Hotel Draken, Göteborg
Chair: Henry Kristian Karlsson
 

Real-world effectiveness of ADHD medications in amphetamine dependence and borderline personality disorder

Milja Hartikainen



•ADHD drug use in Iceland and hospitalization for new-onset psychosis or mania among adults

Ragna Kristín Guðbrandsdóttir, Engilbert Sigurðsson, Halldóra Jónsdóttir, Þorsteinn Ívar Albertsson, Oddur Ingimarsson



ADHD medications and long-term risk of cardiovascular diseases

Le Zhang, Lin Li, Pontus Andell, Miguel Garcia-Argibay, Patrick D. Quinn, Brian M. D’Onofrio, Isabell Brikell, Ralf Kuja-Halkola, Paul Lichtenstein, Kristina Johnell, Henrik Larsson, Zheng Chang

10:00am
-
10:30am
BR5: COFFEE BREAK AND POSTER VIEWING
Location: Hotel Draken, Göteborg
10:30am
-
12:00pm
S4: DEPRESSION
Location: Hotel Draken, Göteborg
Chair: Gregers Wegener
 

Novel trial designs to personalize antidepressant treatment

Daniel Lindqvist



Psilocybin as an antidepressant? Clinical effect and biological correlates

Johan Lundberg



Psychocotropic medication and the fetal brain

Lars Henning Pedersen

12:00pm
-
1:15pm
BR6: LUNCH AND POSTER VIEWING
Location: Hotel Draken, Göteborg
1:15pm
-
2:00pm
PL4: SCNP 2024 Lecture
Location: Hotel Draken, Göteborg
Chair: Sophie Erhardt
 

Treatment resistance in psychotic disorders.

Ingrid Melle, Isabel Kreis, Kristin Fjelnseth Wold

2:00pm
-
2:30pm
BR7: COFFEE BREAK AND POSTER VIEWING
Location: Hotel Draken, Göteborg
2:30pm
-
4:00pm
S5: Schizophrenia
Location: Hotel Draken, Göteborg
Chair: Sophie Erhardt
 

ImmunoPsychiatry – evidence from large-scale studies to detailed clinical studies

Michael Eriksen Benros



Add-on prednisolone vs. placebo in early psychotic disorders: Results of a pilot study.

Erik Johnsen



Studies of glial cells and synaptic markers in early stages of psychosis and clinical high-risk states

Simon Cervenka



Endocannabinoid dysregulation in psychotic disorders

Heikki Laurikainen, Reetta-Liina Armio, Lauri Tuominen, Anna Kirjavainen, Olof Solin, Merja Haaparanta-Solin, Raimo K R Salokangas, Jarmo Hietala

4:00pm
-
4:10pm
PL5: Conclusion and Closure
Location: Hotel Draken, Göteborg
Chair: Sophie Erhardt
Chair: Bo Söderpalm